We are live on ! Find out more
EC

EntryPoint Capital Portfolio holdings

AUM $341M
1-Year Est. Return 20.57%
This Fund
S&P 500
This Quarter Est. Return
+8.02%
1 Year Est. Return
+20.57%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$176M
AUM Growth
+$107M
Cap. Flow
+$103M
Cap. Flow %
58.75%
Top 10 Hldgs %
4.24%
Holding
1,234
New
413
Increased
180
Reduced
1
Closed
640

Top Buys

Rank Stock Value
1
GH icon
Guardant Health
GH
+$895K
2
PLAB icon
Photronics
PLAB
+$774K
3
EW icon
Edwards Lifesciences
EW
+$755K
4
MMS icon
Maximus
MMS
+$754K
5
TTEK icon
Tetra Tech
TTEK
+$745K

Top Sells

Rank Stock Value
1
DK icon
Delek US
DK
+$197K
2
CSGP icon
CoStar Group
CSGP
+$197K
3
VIST icon
Vista Energy
VIST
+$197K
4
SKX
Skechers
SKX
+$196K
5
ALRS icon
Alerus Financial
ALRS
+$195K

Sector Composition

Rank Sector Weight
1 Healthcare 19.45%
2 Technology 17.59%
3 Industrials 17.43%
4 Consumer Discretionary 12.31%
5 Financials 10.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UTMD icon
401
Utah Medical Products
UTMD
$214M
$222K 0.13%
+3,321
New +$225K
VECO icon
402
Veeco
VECO
$3.15B
$222K 0.13%
+6,702
New +$251K
IDA icon
403
Idacorp
IDA
$8.23B
$222K 0.13%
+2,152
New +$215K
CIVI
404
DELISTED
Civitas Resources
CIVI
$221K 0.13%
4,370
+1,880
+76% +$116K
ABG icon
405
Asbury Automotive
ABG
$4.19B
$221K 0.13%
+927
New +$218K
LAB icon
406
Standard BioTools
LAB
$326M
$220K 0.13%
+113,867
New +$223K
AVB icon
407
AvalonBay Communities
AVB
$27.1B
$220K 0.12%
975
+677
+227% +$146K
UA icon
408
Under Armour Class C
UA
$2.92B
$220K 0.12%
+26,263
New +$188K
CRCT icon
409
Cricut
CRCT
$936M
$220K 0.12%
+31,676
New +$190K
BABA icon
410
Alibaba
BABA
$269B
$219K 0.12%
2,062
+1,622
+369% +$133K
NMR icon
411
Nomura Holdings
NMR
$28.7B
$219K 0.12%
+41,871
New +$238K
CNTA
412
DELISTED
Centessa Pharmaceuticals
CNTA
$218K 0.12%
13,651
+5,515
+68% +$67.6K
SXT icon
413
Sensient Technologies
SXT
$5.4B
$218K 0.12%
+2,719
New +$206K
COLD icon
414
Americold
COLD
$4.09B
$218K 0.12%
7,706
+1,429
+23% +$40.8K
TMP icon
415
Tompkins Financial
TMP
$1.45B
$218K 0.12%
+3,768
New +$215K
IBP icon
416
Installed Building Products
IBP
$6.13B
$218K 0.12%
884
+336
+61% +$76K
GSL icon
417
Global Ship Lease
GSL
$1.57B
$218K 0.12%
8,162
+1,220
+18% +$31.3K
KBR icon
418
KBR
KBR
$4.68B
$217K 0.12%
+3,339
New +$217K
VAL icon
419
Valaris
VAL
$5.51B
$217K 0.12%
3,900
+3,390
+665% +$222K
LGIH icon
420
LGI Homes
LGIH
$1.4B
$217K 0.12%
1,834
+327
+22% +$34.5K
BV icon
421
BrightView Holdings
BV
$1.31B
$217K 0.12%
13,799
+12,771
+1,242% +$185K
NABL icon
422
N-able
NABL
$769M
$217K 0.12%
16,629
+14,605
+722% +$195K
GRAB icon
423
Grab
GRAB
$13.5B
$217K 0.12%
+57,087
New +$195K
SWX icon
424
Southwest Gas
SWX
$6.74B
$217K 0.12%
+2,938
New +$212K
C icon
425
Citigroup
C
$222B
$216K 0.12%
+3,453
New +$214K

Similar funds

EntryPoint Capital's Q3 2024 Portfolio in Review

As of Q3 2024, EntryPoint Capital held 1,234 positions worth $176M, up 157% from $68.4M the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.

EntryPoint Capital deployed $103M of net new capital in Q3 2024, opening 413 new positions and adding to 180 existing holdings. Its largest new stake was Guardant Health: 31,633 shares worth $726K.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iRadimed, an estimated $8.4K trimmed.

  • EntryPoint Capital's largest Q3 2024 buy was Guardant Health: 31,633 shares worth $726K.
  • EntryPoint Capital added most to Edwards Lifesciences in Q3 2024, an estimated $755K increase.
  • EntryPoint Capital's biggest Q3 2024 reduction was iRadimed, cutting an estimated $8.4K.
  • EntryPoint Capital fully exited Delek US in Q3 2024, selling an estimated $197K.
  • EntryPoint Capital's ten largest holdings make up 4.2% of its $176M portfolio in Q3 2024.
  • EntryPoint Capital opened 413 new positions and closed 640 in Q3 2024.
  • EntryPoint Capital's portfolio value rose 157% quarter-over-quarter to $176M.

Based on EntryPoint Capital's 13F filing for Q3 2024, filed 13 Nov 2024.